Innovative CME/CE Technology
Unique Critique® is a real-time customizable, interactive, performance-improvement video program providing application-based training and subsequent review of comparative data to the learner, measuring peer-to-peer problem-solving. Up to 75 question and answer scenarios delivered throughout the video case-based learning allow participants to choose a customized learning path and continuously assess the participant during the activity rather than through passive post-program testing.
Using innovative technology, the faculty present(s) personalized video feedback to the participant based on selected answers, thereby providing multiple effective teachable moments. Each pathway is built upon principles of adult learning. Unique Critique provides the look and feel of a live lecture interfaced within a case-based question-answer format upon which a dynamic system captures continuous assessment data for comparative participant evaluation.
Evidence is presented by the expert to substantiate right and wrong decisions made by the user to maximize teachable moments Using a library of digital video clips, extensive branching logic and real-time participant input, the program is tailored to the participant’s individualized learning needs.
Featured Programs
New Therapies, New Competencies in Managing Patients with Opioid Therapy
The role of the retail pharmacist in pain management is complex, including but not limited to monitoring and managing drug therapy, providing patient education, and providing drug information and education to other providers. When controlled substances are involved, the pharmacist is obligated to judge whether the prescription is legally valid and therapeutically appropriate.
The emergence of pending therapeutic options in pain management will require the pharmacist to obtain accurate clinical updates.
Read More
Plotting a Course to Manage Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) consists of 2 very distinct entities: Crohn’s disease and ulcerative colitis. Both conditions have severe symptoms, including abdominal cramping, diarrhea, and rectal bleeding. Both are also associated with a multitude of complications, including an increased risk of colon cancer in patients afflicted with the disease for long periods of time. Because these conditions can affect patients who are of working age, there is a disproportionate effect of IBD on younger patients and those enrolled in the workforce.
Read More
Plotting a Course to Manage Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a progressive, debilitating, and sometimes crippling condition which has a tremendous burden on society and the workforce. Patients with RA may suffer from complications related to joint pathology as well as organ dysfunction, including decreased immune system function, increased cardiovascular risk, and pulmonary complications. In light of this evidence, it is important to consider appropriate and early treatment of this condition.
Read More
One-On-One Expert Discussion About ACS Medication Management
Approximately 64.4 million persons in the United States are affected with some form of cardiovascular disease, which includes hypertension, coronary heart disease, congestive heart failure, stroke, peripheral arterial disease, valvular heart disease and congenital cardiovascular defects. Cardiovascular disease is the number one killer in the US across all patients in all ethnic groups and costs the healthcare system more than $368 billion dollars in 2004 alone.
Read More
Case-Based Approaches to Managing Future Formularies for Immune Mediated Diseases
Case studies will be presented in disease states where a high incidence of cross-utility of biologic therapies is emerging as expanded indications for agents are rapidly occurring. Case studies will include rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, as these disease states invite the greatest discussion regarding a rapidly expanding group of biologic therapies...
Read More
Achieving Total Control: Essential Management of the Complications of Chronic Kidney Disease - Module 1
Recent studies have indicated that the impact of chronic kidney disease (CKD) in managed care is substantial, with average per-member, per-month costs exceeding $4,000 in pre-ESRD patients, and nearly 40% of CKD patients not being appropriately managed by a nephrologist until the initiation of dialysis. Evidence also suggests that CKD patients have poor adherence to medication therapy, lifestyle modifications and risk management, all of which are essential to improve outcomes.
Read More
Achieving Total Control: Maintenance of Cardiovascular Health in Patients with Chronic Kidney Disease - Module 2
Cardiovascular disease is highly prevalent among patients with chronic kidney disease (CKD). CKD is an independent risk factor for the development of coronary artery disease, and is also associated with an adverse effect on prognosis from cardiovascular disease. Hypertension is the second leading cause of CKD in all patients. Thus, achieving and maintaining cardiovascular health in patients with CKD is a primary goal for the multi-disciplinary health team.
Read More
Achieving Total Control: Maintenance of Cardiovascular Health in Patients with Chronic Kidney Disease - Module 3
CType 2 diabetes is the leading cause of chronic kidney disease (CKD) in the developed world, and its control can lead to a slower rate of progression of CKD. Once diabetes has been diagnosed, tight glycemic control can prevent the progression of diabetic complications in the patient with CKD.
Read More